People aged ≥50 years who are household contacts of a person who is immunocompromised are recommended to receive zoster vaccine
People ≥50 years of age who are household contacts of a person who is, or is expected to become, immunocompromised are recommended to receive zoster vaccine. This indirectly protects the immunocompromised household member from exposure to varicella-zoster virus (VZV).
Because the efficacy of zoster vaccines is not 100%, the vaccinated household member may still develop herpes zoster from wild-type VZV.
The rate of VZV-like rashes after Zostavax from the vaccine virus is very low. It is unlikely that vaccine-associated virus would be transmitted from a person recently vaccinated with Zostavax to a susceptible immunocompromised contact.1 VZV from vaccine-associated virus is not possible with Shingrix.
If a vaccinated person develops a varicella- or zoster-like rash after Zostavax, they should:
- cover the rash
- avoid contact with people who are immunocompromised until the rash clears
Page history
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/recommendations/people-aged-50-years-who-are-household-contacts-of-a-person-who-is-immunocompromised.